Company intelligence / Profile preview

Rubin Medical

Malmo, Skåne, Swedendnb.com ↗

Ownership: Private
Development stage: Commercial

Overview

Rubin Medical develops and markets advanced medical devices for the management of type 1 diabetes. Their product portfolio includes insulin pumps and continuous glucose monitoring systems that automatically adjust insulin dosing based on real-time glucose levels. The company is established as a leading distributor and marketer of high-tech diabetes care solutions in Scandinavia, with a strong track record of growth since its founding and acquisition by Indutrade in 2012.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Rubin Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rubin Medical.

Explore the full profile